Literature DB >> 7035600

Lack of oral tolerance in C3H/HeJ mice.

H Kiyono, J R McGhee, M J Wannemuehler, S M Michalek.   

Abstract

Daily gastric intubation of lipopolysaccharide (LPS)-responsive C3H/HeN, BALB/c, and Swiss mice with SRBC for 2 wk resulted in oral tolerance, whereas similarly treated LPS-nonresponsive C3H/HeJ mice gave splenic anti-SRBC PFC responses, including the IgA isotype, after systemic challenge with antigen. Oral tolerance in LPS-responsive C3H/HeN mice was due to T suppressor (Ts) cells because significant Ts cell activity was demonstrated in both Peyer's patches (PP) and spleens of these animals. On the other hand, T cells from PP and spleens of identically treated C3H/HeJ mice exhibited mainly T helper cell activity. Prior treatment of PP or spleen cell preparations from tolerant C3H/HeN mice with anti-Lyt-2.1 resulted in good in vitro anti-SRBC PFC responses, especially IgA isotype responses in PP cell cultures. These results indicate that oral administration of a thymic-dependent antigen (SRBC) to LPS-responsive mice induced a Ts cell population in PP, which, after migration to peripheral lymphoid tissue (e.g., spleen), suppressed responses to systemically administered antigen. LPS-nonresponsive mice lack this Ts cell pathway and continually respond to oral administration of antigen.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7035600      PMCID: PMC2186596          DOI: 10.1084/jem.155.2.605

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  11 in total

1.  Effects of antigen-feeding on intestinal and systemic immune responses. III. Antigen-specific serum-mediated suppression of humoral antibody responses after antigen feeding.

Authors:  M F Kagnoff
Journal:  Cell Immunol       Date:  1978-09-15       Impact factor: 4.868

2.  Cellular basis for elevated IgA responses in C3H/HeJ mice.

Authors:  H Kiyono; J L Babb; S M Michalek; J R McGhee
Journal:  J Immunol       Date:  1980-08       Impact factor: 5.422

Review 3.  Oral tolerance.

Authors:  T B Tomasi
Journal:  Transplantation       Date:  1980-05       Impact factor: 4.939

4.  Immunologic suppression after oral administration of antigen. I. Specific suppressor cells formed in rat Peyer's patches after oral administration of sheep erythrocytes and their systemic migration.

Authors:  J A Mattingly; B H Waksman
Journal:  J Immunol       Date:  1978-11       Impact factor: 5.422

5.  Modulation of immune response by bacterial lipopolysaccharide (LPS): multifocal effects of LPS-induced suppression of the primary antibody response to a T-dependent antigen.

Authors:  T Uchiyama; D M Jacobs
Journal:  J Immunol       Date:  1978-12       Impact factor: 5.422

6.  A mechanism for the induction of immunological tolerance by antigen feeding: antigen-antibody complexes.

Authors:  C André; J F Heremans; J P Vaerman; C L Cambiaso
Journal:  J Exp Med       Date:  1975-12-01       Impact factor: 14.307

7.  Systemic tolerance and secretory immunity after oral immunization.

Authors:  S J Challacombe; T B Tomasi
Journal:  J Exp Med       Date:  1980-12-01       Impact factor: 14.307

8.  The Qa-1 antigenic system. Relation of Qa-1 phenotypes to lymphocyte sets, mitogen responses, and immune functions.

Authors:  T H Stanton; C E Calkins; J Jandinski; D J Schendel; O Stutman; H Cantor; E A Boyse
Journal:  J Exp Med       Date:  1978-10-01       Impact factor: 14.307

9.  Cellular requirements for lipopolysaccharide adjuvanticity. A role for both T lymphocytes and macrophages for in vitro responses to particulate antigens.

Authors:  J R McGhee; J J Farrar; S M Michalek; S E Mergenhagen; D L Rosenstreich
Journal:  J Exp Med       Date:  1979-04-01       Impact factor: 14.307

10.  Two distinct antigen-specific suppressor factors induced by the oral administration of antigen.

Authors:  J A Mattingly; J M Kaplan; C A Janeway
Journal:  J Exp Med       Date:  1980-09-01       Impact factor: 14.307

View more
  30 in total

1.  T cell-mediated oral tolerance is intact in germ-free mice.

Authors:  K L W Walton; J A Galanko; R Balfour Sartor; N C Fisher
Journal:  Clin Exp Immunol       Date:  2006-03       Impact factor: 4.330

Review 2.  Oral tolerance.

Authors:  W Strober; B Kelsall; T Marth
Journal:  J Clin Immunol       Date:  1998-01       Impact factor: 8.317

Review 3.  A T cell/B cell/epithelial cell internet for mucosal inflammation and immunity.

Authors:  K Fujihashi; M N Kweon; H Kiyono; J L VanCott; F W van Ginkel; M Yamamoto; J R McGhee
Journal:  Springer Semin Immunopathol       Date:  1997

Review 4.  Homeostatic Immunity and the Microbiota.

Authors:  Yasmine Belkaid; Oliver J Harrison
Journal:  Immunity       Date:  2017-04-18       Impact factor: 31.745

Review 5.  Mechanisms of adaptation and progression in idiosyncratic drug induced liver injury, clinical implications.

Authors:  Lily Dara; Zhang-Xu Liu; Neil Kaplowitz
Journal:  Liver Int       Date:  2015-11-11       Impact factor: 5.828

Review 6.  Role of the microbiota in immunity and inflammation.

Authors:  Yasmine Belkaid; Timothy W Hand
Journal:  Cell       Date:  2014-03-27       Impact factor: 41.582

7.  Effect of the gastrointestinal microflora on induction and maintenance of oral tolerance to ovalbumin in C3H/HeJ mice.

Authors:  M C Moreau; G Corthier
Journal:  Infect Immun       Date:  1988-10       Impact factor: 3.441

8.  Divergent effects of bacterial lipopolysaccharide on immunity to orally administered protein and particulate antigens in mice.

Authors:  A M Mowat; M J Thomas; S MacKenzie; D M Parrott
Journal:  Immunology       Date:  1986-08       Impact factor: 7.397

9.  Immunohistochemical examination of Peyer's patches in autoimmune mice.

Authors:  H Yoshioka; G Ohshio; F Furukawa; M Inada; S Miyata; Y Hamashima; T Miyake
Journal:  Histochemistry       Date:  1988

10.  Murine model of buckwheat allergy by intragastric sensitization with fresh buckwheat flour extract.

Authors:  Soo-Young Lee; Sejo Oh; Kisun Lee; Young-Ju Jang; Myung-Hyun Sohn; Kyoung-En Lee; Kyu-Earn Kim
Journal:  J Korean Med Sci       Date:  2005-08       Impact factor: 2.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.